Ordeniza, Baby Boy .
HRN: 29-32-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
AMPICILLIN 250MG (VIAL)
07/17/2026
07/24/2026
IV
125mg
Q12H
PSNB (THICKLY MSAF)
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes